首页> 外国专利> Acetamide derivatives, replaced by N-hetero or 2-hetero compounds, act as modulators of signal wave groups; synthesize drugs containing these components; and their use in cancer treatment, rejecting Rio n transplantation, osteitis, Parkinson's and so on.

Acetamide derivatives, replaced by N-hetero or 2-hetero compounds, act as modulators of signal wave groups; synthesize drugs containing these components; and their use in cancer treatment, rejecting Rio n transplantation, osteitis, Parkinson's and so on.

机译:乙酰胺衍生物被N杂或2杂化合物取代,充当信号波基团的调节剂。合成含有这些成分的药物;及其在癌症治疗中的用途,拒绝里约热内卢移植,骨炎,帕金森氏病等。

摘要

Compounds derived from Acetamidas replaced by N - (hetero) and 2 - aryl - aryl - (hetero),Pharmaceutical modulators of Wnt; composition; method to inhibit WNT signaling; and its use for the treatment of keloids, fibrosis, proteinuria, kidney graft rejection, Osteoarthritis,Retinopathy, among others.
机译:由N-(杂)和2-芳基-芳-(杂)取代的酰胺类化合物,Wnt的药物调节剂;组成;抑制WNT信号的方法;其用于治疗瘢痕loid,纤维化,蛋白尿,肾移植排斥,骨关节炎,视网膜病变等。

著录项

  • 公开/公告号CL2011002116A1

    专利类型

  • 公开/公告日2012-01-27

    原文格式PDF

  • 申请/专利权人 NOVARTIS AG.;

    申请/专利号CL20110002116

  • 申请日2011-08-30

  • 分类号A61K31/44;A61P17/00;A61P19/10;A61P35/00;C07D213/75;C07D401/12;C07D401/14;C07D403/12;C07D413/14;C07D417/12;C07D417/14;

  • 国家 CL

  • 入库时间 2022-08-21 17:25:20

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号